Human basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoprotein by Ragotte, RJ, Pulido, D, Donnellan, FR, Gorini, G, Davies, H, Brun, J, King, LDW, Skinner, K, Draper, SJ

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5 by Harrison, TE, Alam, N, Farrell, B, Quinkert, D, Lias, AM, King, LDW, Barfod, LK, Draper, SJ, Campeotto, I, Higgins, MK

Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies by Willcox, AC, Huber, AS, Diouf, A, Barrett, JR, Silk, SE, Pulido, D, King, LDW, Alanine, DGW, Minassian, AM, Diakite, M, Draper, SJ, Long, CA, Miura, K

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens by Barrett, JR, Silk, SE, Mkindi, CG, Kwiatkowska, KM, Hou, MM, Lias, AM, Kalinga, WF, Mtaka, IM, McHugh, K, Bardelli, M, Davies, H, King, LDW, Edwards, NJ, Chauhan, VS, Mukherjee, P, Rwezaula, S, Chitnis, CE, Olotu, AI, Minassian, AM, Draper, SJ, Nielsen, CM

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting by Healer, J, Thompson, JK, Mackwell, KL, Browne, CD, Seager, BA, Ngo, A, Lowes, KN, Silk, SE, Pulido, D, King, LDW, Christen, JM, Noe, AR, Kotraiah, V, Masendycz, PJ, Rajagopalan, R, Lucas, L, Stanford, MM, Soisson, L, Diggs, C, Miller, R, Youll, S, Wycherley, K, Draper, SJ, Cowman, AF

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex by Williams, BG, King, LDW, Pulido, D, Quinkert, D, Lias, AM, Silk, SE, Ragotte, RJ, Davies, H, Barrett, JR, McHugh, K, Rigby, CA, Alanine, DGW, Barfod, L, Shea, MW, Cowley, LA, Dabbs, RA, Pattinson, DJ, Douglas, AD, Lyth, OR, Illingworth, JJ, Jin, J, Carnrot, C, Kotraiah, V, Christen, JM, Skinner, K, Higgins, MK, Draper, SJ

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults by Silk, SE, Kalinga, WF, Mtaka, IM, Lilolime, NS, Mpina, M, Milando, F, Ahmed, S, Diouf, A, Mkwepu, F, Simon, B, Athumani, T, Rashid, M, Mohammed, L, Lweno, O, Ali, AM, Nyaulingo, G, Mwalimu, B, Mswata, S, Mwamlima, TG, Barrett, JR, Wang, LT, Themistocleous, Y, King, LDW, Hodgson, SH, Payne, RO, Nielsen, CM, Lawrie, AM, Nugent, FL, Cho, J-S, Long, CA, Miura, K, Draper, SJ, Minassian, AM, Olotu, AI

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection by Hou, M, Barrett, JR, Themistocleous, Y, Rawlinson, TA, Diouf, A, Martinez, FJ, Nielsen, CM, Lias, AM, King, LDW, Edwards, NJ, Greenwood, NM, Kingham, L, Poulton, I, Khozoee, B, Goh, C, Hodgson, SH, Mac lochlainn, D, Salkeld, J, Guillotte-Blisnick, M, Huon, C, Mohring, F, Reimer, JM, Chauhan, VS, Biswas, S, Lawrie, AM, Silk, SE, Minassian, AM, Draper, SJ, Mukherjee, P, Taylor, IJ, Cho, J, Nugent, FL, Long, CA, Moon, RW, Miura, K, Chitnis, CE

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies by King, LDW, Pulido, D, Barrett, JR, Davies, H, Quinkert, D, Lias, AM, Silk, SE, Pattinson, DJ, Diouf, A, Williams, BG, McHugh, K, Rodrigues, A, Rigby, CA, Strazza, V, Suurbaar, J, Rees-Spear, C, Dabbs, RA, Ishizuka, AS, Zhou, Y, Gupta, G, Jin, J, Li, Y, Carnrot, C, Minassian, AM, Campeotto, I, Fleishman, SJ, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Long, CA, Miura, K, Ashfield, R, Skinner, K, Howarth, MR, Biswas, S, Draper, SJ

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial by Silk, SE, Kalinga, WF, Salkeld, J, Mtaka, IM, Ahmed, S, Milando, F, Diouf, A, Bundi, CK, Balige, N, Hassan, O, Mkindi, CG, Rwezaula, S, Athumani, T, Mswata, S, Lilolime, NS, Simon, B, Msami, H, Mohamed, M, David, DM, Mohammed, L, Nyaulingo, G, Mwalimu, B, Juma, O, Mwamlima, TG, Sasamalo, IA, Mkumbange, RP, Kamage, JJ, Barrett, JR, King, LDW, Hou, MM, Pulido, D, Carnrot, C, Lawrie, AM, Cowan, RE, Nugent, FL, Roberts, R, Cho, J-S, Long, CA, Nielsen, CM, Miura, K, Draper, SJ, Olotu, AI, Minassian, AM

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype by Barrett, JR, Pipini, D, Wright, ND, Cooper, AJR, Gorini, G, Quinkert, D, Lias, AM, Davies, H, Rigby, CA, Aleshnick, M, Williams, BG, Bradshaw, WJ, Paterson, NG, Martinson, T, Kirtley, P, Picard, L, Wiggins, CD, Donnellan, FR, King, LDW, Wang, LT, Popplewell, JF, Silk, SE, de Ruiter Swain, J, Skinner, K, Kotraiah, V, Noe, AR, MacGill, RS, King, CR, Birkett, AJ, Soisson, LA, Minassian, AM, Lauffenburger, DA, Miura, K, Long, CA, Wilder, BK, Koekemoer, L, Tan, J, Nielsen, CM, McHugh, K, Draper, SJ